<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="correction" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id><journal-id journal-id-type="pmc-domain-id">16</journal-id><journal-id journal-id-type="pmc-domain">bmccanc</journal-id><journal-title-group><journal-title>BMC Cancer</journal-title></journal-title-group><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10131375</article-id><article-id pub-id-type="pmcid-ver">PMC10131375.1</article-id><article-id pub-id-type="pmcaid">10131375</article-id><article-id pub-id-type="pmcaiid">10131375</article-id><article-id pub-id-type="pmid">37101117</article-id><article-id pub-id-type="doi">10.1186/s12885-023-10879-2</article-id><article-id pub-id-type="publisher-id">10879</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Characteristics and outcomes of patients with <italic toggle="yes">RET</italic>-fusion positive non-small lung cancer in real-world practice in the United States</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3631-3941</contrib-id><name name-style="western"><surname>Hess</surname><given-names initials="LM">Lisa M.</given-names></name><address><email>Hess_lisa_m@lilly.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Han</surname><given-names initials="Y">Yimei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="YE">Yajun Emily</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bhandari</surname><given-names initials="NR">Naleen Raj</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sireci</surname><given-names initials="A">Anthony</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.417540.3</institution-id><institution-id institution-id-type="ISNI">0000 0000 2220 2544</institution-id><institution>Eli Lilly and Company, </institution></institution-wrap>Indianapolis, IN 46254 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.511691.b</institution-id><institution>Loxo Oncology at Lilly, a wholly owned subsidiary of Eli Lilly and Company, </institution></institution-wrap>Stamford, CT USA </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">425102</issue-id><elocation-id>382</elocation-id><pub-history><event event-type="pmc-release"><date><day>26</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>27</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-04-28 13:25:13.543"><day>28</day><month>04</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12885_2023_Article_10879.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" xml:lang="en" xlink:title="research-article" journal-id="BMC Cancer" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC7786962"><article-title>Characteristics and outcomes of patients with <italic>RET</italic>-fusion positive non-small lung cancer in real-world practice in the United States</article-title><volume>21</volume><date><day>5</day><month>1</month><year>2021</year></date><elocation-id>28</elocation-id><source>BMC Cancer</source><pub-id pub-id-type="doi">10.1186/s12885-020-07714-3</pub-id><pub-id pub-id-type="pmcid">PMC7786962</pub-id><pub-id pub-id-type="pmid">33402119</pub-id></related-article><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">
<bold>Correction: </bold>
<bold><italic toggle="yes">BMC Cancer </italic></bold>
<bold>21, 28 (2021)</bold>
</p><p id="Par2">
10.1186/s12885-020-07714-3
</p><p id="Par3">Following publication of the original article [<xref ref-type="bibr" rid="CR1">1</xref>], the authors identified an error in the caption of table 4.</p><p id="Par4">In the published article [<xref ref-type="bibr" rid="CR1">1</xref>], the title of Table&#160;4 is &#8220;Progression-free and overall survival of RET&#8201;+&#8201;versus RET- cohorts from start of first-line therapy,&#8221; which should be corrected to read &#8220;Progression-free and overall survival of <bold>RET-</bold> versus <bold>RET&#8201;+</bold>&#8201;cohorts from start of first-line therapy,&#8221; (correction in bold) to correctly indicate the direction of the hazard ratios.</p></body><back><fn-group><fn><p>The online version of the original article can be found at 10.1186/s12885-020-07714-3</p></fn><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Hess LM, Han Y, Zhu YE, et al. Characteristics and outcomes of patients with <italic toggle="yes">RET</italic>-fusion positive non-small lung cancer in real-world practice in the United States. BMC Cancer. 2021;21:28. 10.1186/s12885-020-07714-3.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-020-07714-3</pub-id><pub-id pub-id-type="pmcid">PMC7786962</pub-id><pub-id pub-id-type="pmid">33402119</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>